跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nahaltin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nahaltin
Approved
STANDARD
Nahaltin
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
71f08d3f8d095163
Company
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Type
Standard
Approval Details
Approval Id
71f08d3f8d095163
Drug Approval Philippines Name
Nahaltin
Product Name
Nahaltin
Registration Number
DR-XY38701
Brand Name
Nahaltin
Generic Name
Co-Amoxiclav
Dosage Form
Tablet
Dosage Strength
375 mg
Manufacturer
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Importer
Sahar International Trading, Inc.
Distributor
Amson Pharmaceuticals
Company Detail Path
/organization/cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd
Issuance Date
25 October 2022
Expiry Date
25 October 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
71f08d3f8d095163
Type
Standard
Back to Philippines FDA Approvals